Rankia is the leading Spanish-speaking financial community worldwide, boasting over 500,000 registered users. As the voice behind the YouTube channel "Rankia" (@rankia), this platform extends Rankia's mission, established in February 2003, to bring transparency to the complex financial sector. With over 145,000 subscribers, the channel serves as a vital resource for individuals seeking to make informed financial decisions. The content creator focuses on a variety of topics, including the stock market, investment funds, finance, stocks, how to invest in the stock market, stock market courses, investing money, investing in stocks, equities, fixed income, and financial freedom. The channel is dedicated to helping users and readers navigate the financial world, offering a space for investors and consumers to resolve doubts, exchange opinions, and share information. Through forums, blogs, webinars, courses, and community events, Rankia provides valuable tools and insights to compare investment options and choose products that best suit individual needs, making it an essential destination for those seeking investment insights and analysis of market trends.
by Rankia | 13/03/2025 09:00 AM | BA.L
🛡️ BAE Systems is a major player in defense, security, and aerospace, exporting its innovations to over 100 countries.
🚀 The company's operating profit has grown by 80% since 2020, driven by increased defense contracts.
💸 BAE Systems has record free cash flow of over $2.5 billion in 2024, allowing for investment in new defense systems.
⚖️ While many defense companies have high P/E ratios, BAE Systems' P/E ratio of around 30 is comparatively less excessive.
Read more!
by Rankia | 09/03/2025 09:00 AM | ABBV
🛡️ AbbVie is a major pharmaceutical company with a strong presence in immunology, oncology, and neuroscience.
📈 The company has shown consistent revenue growth and maintains high operating margins.
💰 AbbVie offers an attractive dividend yield and has a history of increasing dividends annually.
💼 Its acquisition of Allergan strengthened its position in the anti-aging market, particularly with aesthetic treatments.
Read more!
by Rankia | 09/03/2025 09:00 AM | Blog
🔬 United Biotechnology focuses on developing therapies to combat cellular aging by eliminating senescent cells.
⚠️ The company has yet to generate profits, making it a highly speculative investment.
📈 It may be suitable for active investors employing options strategies or those anticipating a resurgence in the biopharma sector.
📉 Investors should be cautious, as the stock price tends to revert to its average after the hype fades.
Read more!
by Rankia | 09/03/2025 09:00 AM | Blog
👵 The iShares Aging Population UCITS ETF focuses on companies benefiting from the aging population (60+ years).
🌍 It replicates the STOXX Global Ageing Population index, covering the needs of the senior population worldwide.
✅ The ETF uses a sampling technique, selecting a representative sample of the index values instead of buying all 300 values.
💰 It has a TER of 0.40%, making it an affordable option, and has shown a revaluation of 23% in the last three years.
Read more!
by Rankia | 02/03/2025 07:00 AM | REMX
💰 The VanEck Rare Earth and Strategic Metals ETF (REMX) is highlighted as a key investment vehicle for exposure to the rare earth elements sector.
📈 REMX tracks the MVIS Global Rare Earth/Strategic Metals Index, encompassing the largest and most liquid companies in the rare earth and strategic metals industry.
✅ With a competitive expense ratio of 0.59% annually and a physical replication strategy, REMX offers investors a cost-effective way to benefit from the long-term growth potential of the sector.
🔄 The ETF reinvests dividends, enhancing returns through compound growth.
Read more!
